TAPP2 Antibodies

Santa Cruz Biotechnology offers a broad range of TAPP2 monoclonal antibodies for investigating TAPP2 in cellular processes. TAPP2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TAPP2, or T-cell-activated protein 2, functions as an adaptor protein involved in signaling pathways that regulate cell growth, differentiation, and survival. Research has shown TAPP2's significant role in immune response regulation. TAPP2 expression patterns have been linked to various diseases, including cancer and autoimmune disorders. Understanding TAPP2's molecular mechanisms and interactions provides valuable insights into cellular signaling networks. Investigating TAPP2 functionality helps identify potential therapeutic approaches for treating associated conditions. Current research continues to uncover new aspects of TAPP2's biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of TAPP2's role in health and disease.